Health-care companies rose as traders rotated back into the sector amid optimism about blockbuster drugs. Novo Nordisk shares rose by more than 8% for one of their biggest gains in recent years after ...

Novo Nordisk (NVO) has reportedly been criticized by a U.K. pharma industry group for mischaracterizing certain payments to ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

President-elect Trump's threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland could disrupt one export that is wildly popular in America: Ozempic. ...

A month’s supply of Ozempic is close to $1,000 without insurance, though manufacturer coupons and patient assistance programs ...

As a patient ... For Novo Nordisk, the site is clearly about supporting greater access to their medicines in the US and Puerto Rico, and in particular to support their financial assistance programme.

and so on 50 Patient Advocate Foundation Copay assistance, and provides the National Financial Assistance Resource Directory (covers chronic conditions including cancer) and the Scholarships for ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

although there is a good chance they will recover and still deliver strong returns to patient investors. But which one is likely to perform better than the other? Let's find out. Novo Nordisk has ...